Marinus Pharmaceuticals reported $70.35M in Loan Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
ALKERMES ALKS:US 291.54M 634K
Amgen AMGN:US $ 35705M 305M
Biogen BIIB:US $ 6277.4M 1.7M
Eisai 4523:JP Y 84905M 9988M
Enanta Pharmaceuticals ENTA:US $ 1.51M 0M
Esperion Therapeutics ESPR:US $ 259.08M 402K
Intercept Pharmaceuticals ICPT:US $ 713.86M 3.03M
Intra Cellular Therapies ITCI:US $ 0M 0M
Marinus Pharmaceuticals MRNS:US $ 70.35M 0.42M
Neurocrine Biosciences NBIX:US $ 169M 208.7M
Ptc Therapeutics PTCT:US $ 981.44M 5.79M
Regeneron Pharmaceuticals REGN:US $ 2700.7M 0.3M
Sarepta Therapeutics SRPT:US $ 1100.87M 2.03M
Supernus Pharmaceuticals SUPN:US $ 0M 400.38M
Vertex Pharmaceuticals VRTX:US $ 482.3M 13.2M
YTE INCY:US $ 31.16M 0.23M